Table of Contents

1. Research Objectives and Assumptions
   • Research Objectives
   • Assumptions
   • Abbreviations
2. Market Purview
   • Report Description
     • Market Definition and Scope
   • Executive Summary
     • Market Snippet, By Drug Class
     • Market Snippet, By Application
     • Market Snippet, By Sales Channel
     • Market Snippet, By Region
   • Coherent Opportunity Map (COM)
3. Market Dynamics, Regulations, and Trends Analysis
   • Market Dynamics
     • Drivers
     • Restraints
     • Opportunities
   • Key Highlights
   • Regulatory Scenario
   • Recent Trends
   • Product Launches/Approvals
   • PEST Analysis
   • PORTER’s Analysis
   • Mergers, Acquisitions, and Collaborations
4. Global Controlled Substance Market – Impact of Coronavirus (COVID-19) Pandemic
   • COVID-19 Epidemiology
   • Supply Side and Demand Side Analysis
   • Economic Impact
5. Global Controlled Substance Market, By Drug Class, 2018-2030, (US$ Bn)
   • Introduction
     • Market Share Analysis, 2023 and 2030 (%)
     • Y-o-Y Growth Analysis, 2019 – 2030
     • Segment Trends
   • Opioids
     • Introduction
     • Market Size and Forecast, and Y-o-Y Growth, 2018-2030, (US$ Bn)
   • Stimulants
     • Introduction
     • Market Size and Forecast, and Y-o-Y Growth, 2018-2030, (US$ Bn)
   • Depressants
     • Introduction
     • Market Size and Forecast, and Y-o-Y Growth, 2018-2030, (US$ Bn)
   • Hallucinogens
     • Introduction
     • Market Size and Forecast, and Y-o-Y Growth, 2018-2030, (US$ Bn)
   • Anabolic Steroids
     • Introduction
     • Market Size and Forecast, and Y-o-Y Growth, 2018-2030, (US$ Bn)
   • Others
     • Introduction
     • Market Size and Forecast, and Y-o-Y Growth, 2018-2030, (US$ Bn)
6. Global Controlled Substance Market, By Application, 2018-2030, (US$ Bn)
   • Introduction
     • Market Share Analysis, 2023and 2030 (%)
     • Y-o-Y Growth Analysis, 2019– 2030
     • Segment Trends
   • Pain Management
     • Introduction
     • Market Size and Forecast, and Y-o-Y Growth, 2018-2030, (US$ Bn)
   • Anxiety
     • Introduction
     • Market Size and Forecast, and Y-o-Y Growth, 2018-2030, (US$ Bn)
   • Insomnia
     • Introduction
     • Market Size and Forecast, and Y-o-Y Growth, 2018-2030, (US$ Bn)
   • Cough Suppression
     • Introduction
     • Market Size and Forecast, and Y-o-Y Growth, 2018-2030, (US$ Bn)
   • Attention Deficit Hyperactivity Disorder (ADHD)
     • Introduction
     • Market Size and Forecast, and Y-o-Y Growth, 2018-2030, (US$ Bn)
   • Narcolepsy
     • Introduction
     • Market Size and Forecast, and Y-o-Y Growth, 2018-2030, (US$ Bn)
   • Others
     • Introduction
     • Market Size and Forecast, and Y-o-Y Growth, 2018-2030, (US$ Bn)
7. Global Controlled Substance Market, By Sales Channel, 2018-2030, (US$ Bn)
   • Introduction
     • Market Share Analysis, 2023and 2030 (%)
     • Y-o-Y Growth Analysis, 2019– 2030
     • Segment Trends
   • Hospitals & Clinics
     • Introduction
     • Market Size and Forecast, and Y-o-Y Growth, 2018-2030, (US$ Bn)
   • Pharmacies
     • Introduction
     • Market Size and Forecast, and Y-o-Y Growth, 2018-2030, (US$ Bn)
   • Others (Academic & Research Institutes, etc.)
     • Introduction
     • Market Size and Forecast, and Y-o-Y Growth, 2018-2030, (US$ Bn)
8. Global Controlled Substance Market, By Region, 2018-2030, (US$ Bn)
   • Introduction
     • Market Share Analysis, By Region, 2023and 2030 (%)
     • Y-o-Y Growth Analysis, For Region, 2019–2030
     • Country Trends
   • North America
     • Introduction
     • Market Size and Forecast, and Y-o-Y Growth, By Drug Class, 2018-2030, (US$ Bn)
     • Market Size and Forecast, and Y-o-Y Growth, By Application, 2018-2030, (US$ Bn)
     • Market Size and Forecast, and Y-o-Y Growth, By Sales Channel, 2018-2030, (US$ Bn)
     • Market Size and Forecast, and Y-o-Y Growth, By Country, 2018-2030, (US$ Bn)
       • U.S.
       • Canada
   • Europe
     • Introduction
     • Market Size and Forecast, and Y-o-Y Growth, By Drug Class, 2018-2030, (US$ Bn)
     • Market Size and Forecast, and Y-o-Y Growth, By Application, 2018-2030, (US$ Bn)
     • Market Size and Forecast, and Y-o-Y Growth, By Sales Channel, 2018-2030, (US$ Bn)
     • Market Size and Forecast, and Y-o-Y Growth, By Country, 2018-2030, (US$ Bn)
       • Germany
       • U.K.
       • Spain
       • France
       • Italy
       • Russia
       • Rest of Europe
   • Asia Pacific
     • Introduction
     • Market Size and Forecast, and Y-o-Y Growth, By Drug Class, 2018-2030, (US$ Bn)
     • Market Size and Forecast, and Y-o-Y Growth, By Application, 2018-2030, (US$ Bn)
     • Market Size and Forecast, and Y-o-Y Growth, By Sales Channel, 2018-2030, (US$ Bn)
     • Market Size and Forecast, and Y-o-Y Growth, By Country, 2018-2030, (US$ Bn)
       • China
       • India
       • Japan
       • Australia
       • South Korea
       • ASEAN
       • Rest of Asia Pacific
   • Latin America
     • Introduction
     • Market Size and Forecast, and Y-o-Y Growth, By Drug Class, 2018-2030, (US$ Bn)
     • Market Size and Forecast, and Y-o-Y Growth, By Application, 2018-2030, (US$ Bn)
     • Market Size and Forecast, and Y-o-Y Growth, By Sales Channel, 2018-2030, (US$ Bn)
     • Market Size and Forecast, and Y-o-Y Growth, By Country, 2018-2030, (US$ Bn)
       • Brazil
       • Argentina
       • Mexico
       • Rest of Latin America
   • Middle East
     • Introduction
     • Market Size and Forecast, and Y-o-Y Growth, By Drug Class, 2018-2030, (US$ Bn)
     • Market Size and Forecast, and Y-o-Y Growth, By Application, 2018-2030, (US$ Bn)
     • Market Size and Forecast, and Y-o-Y Growth, By Sales Channel, 2018-2030, (US$ Bn)
     • Market Size and Forecast, and Y-o-Y Growth, By Country, 2018-2030, (US$ Bn)
       • GCC Countries
       • Israel
       • Rest of Middle East
   • Africa
     • Introduction
     • Market Size and Forecast, and Y-o-Y Growth, By Drug Class, 2018-2030, (US$ Bn)
     • Market Size and Forecast, and Y-o-Y Growth, By Application, 2018-2030, (US$ Bn)
     • Market Size and Forecast, and Y-o-Y Growth, By Sales Channel, 2018-2030, (US$ Bn)
     • Market Size and Forecast, and Y-o-Y Growth, By Country/Region , 2018-2030, (US$ Bn)
       • South Africa
       • North Africa
       • Central Africa
9. Competitive Landscape
   • Company Profile
     • Johnson & Johnson Services, Inc.
       • Company Highlights
       • Product Portfolio
       • Key Developments
       • Financial Performance
       • Strategies
     • Pfizer Inc.
       • Company Highlights
       • Product Portfolio
       • Key Highlights
       • Financial Performance
       • Strategies
     • Sanofi
       • Company Highlights
       • Product Portfolio
       • Key Highlights
       • Financial Performance
       • Strategies
     • Merck & Co., Inc.
       • Company Highlights
       • Product Portfolio
       • Key Highlights
       • Financial Performance
       • Strategies
     • Gilead Sciences, Inc.
       • Company Highlights
       • Product Portfolio
       • Key Highlights
       • Financial Performance
       • Strategies
     • Amgen Inc.
       • Company Highlights
       • Product Portfolio
       • Key Highlights
       • Financial Performance
       • Strategies
     • Novartis Pharmaceuticals Corporation
       • Company Highlights
       • Product Portfolio
       • Key Highlights
       • Financial Performance
       • Strategies
     • AbbVie Inc.
       • Company Highlights
       • Product Portfolio
       • Key Highlights
       • Financial Performance
       • Strategies
     • GSK Plc.
       • Company Highlights
       • Product Portfolio
       • Key Highlights
       • Financial Performance
       • Strategies
     • AstraZeneca
       • Company Highlights
       • Product Portfolio
       • Key Highlights
       • Financial Performance
       • Strategies
     • Bristol-Myers Squibb Company
       • Company Highlights
       • Product Portfolio
       • Key Developments
       • Financial Performance
       • Strategies
     • Eli Lilly and Company
       • Company Highlights
       • Product Portfolio
       • Key Highlights
       • Financial Performance
       • Strategies
     • Teva Pharmaceutical Inc.
       • Company Highlights
       • Product Portfolio
       • Key Highlights
       • Financial Performance
       • Strategies
     • Bayer AG
       • Company Highlights
       • Product Portfolio
       • Key Highlights
       • Financial Performance
       • Strategies
     • Novo Nordisk A/S
       • Company Highlights
       • Product Portfolio
       • Key Highlights
       • Financial Performance
       • Strategies
     • Takeda Pharmaceutical Company Limited
       • Company Highlights
       • Product Portfolio
       • Key Highlights
       • Financial Performance
       • Strategies
     • Boehringer Ingelheim International GmbH
       • Company Highlights
       • Product Portfolio
       • Key Highlights
       • Financial Performance
       • Strategies
     • Aspen Holdings
       • Company Highlights
       • Product Portfolio
       • Key Highlights
       • Financial Performance
       • Strategies
     • Astellas Pharma Inc.
       • Company Highlights
       • Product Portfolio
       • Key Highlights
       • Financial Performance
       • Strategies
     • Analysts’ Views
10. Section
    • References
    • Research Methodology
    • About us

*Browse 35 market data tables and 38 figures on “Global Controlled Substance Market” - Global forecast to 2030